Arjun Krishnan

@compbiologist.bsky.social

ML/AI methods & tools for using massive public data collections to gain insights into complex disease mechanisms. Associate Professor & Group leader thekrishnanlab.org at the Dept. of Biomedical Informatics at CU Anschutz.

🧬 AI in Genomics Symposium next week! We're bringing together leading scientists from across academia and industry pushing the boundaries of AI in genomics research Join us May 8 at the University of Chicago - KCBD Auditorium, 9:30–5:00, reception to follow. No registration needed!

Bild

Enjoyed working w/ Stephen & Agnes on this! Gave me a chance to think systematically about where AI 🤖 can backstop human 🧑🏼‍🔬 fallibilities in peer review (fatigue, ordering effects, bias) vs. where human judgment remains essential (novelty, feasibility, creative leaps) while grappling w/ the risks.

Stephen Turner@stephenturner.us · 5mo ago

Peer review reliability is shockingly low. Meta-analyses show reviewer agreement barely above chance, and grant outcomes often depend more on who reviews than what's proposed. Our new preprint with Agnes Urban and Arjun Krishnan @compbiologist.bsky.social : papers.ssrn.com/sol3/papers.... 🧵 1/

Happy to share this new, very intentional chapter. I have left UCLA after 14 years to join the University of Colorado Anschutz as Professor of Biomedical Informatics and Neurosurgery and the inaugural Marsico Chair in Excellence in Functional Precision Medicine/n news.cuanschutz.edu/dbmi/cu-ansc...

CU Anschutz Recruits National Leader to Launch Functional Personalized Medicine Initiative

CU Anschutz welcomes Alice Soragni to launch a Functional Personalized Medicine Initiative using rapid tumor organoid testing to guide treatment decisions.

news.cuanschutz.edu

I'm looking forward to re-teaching: Rethinking Data Analysis — A researcher’s guide to avoiding missteps and misuse This is an advanced short course on developing a mental toolkit for rigorous practice & critical consumption of statistical data analyses. 🧵 1/4

HMGP 7622
Rethinking Data Analysis — A researcher’s guide to avoiding missteps and misuse
Feb 3 – May 5, 2026 | Tue 2–3:30p

OVERVIEW
This is a short (1-credit) course designed to:
1) Discuss common misunderstandings & typical errors in the practice of statistical data analysis.
2) Provide a mental toolkit for critically thinking about statistical methods and results.

TOPICS
Estimating error, uncertainty • Underpowered statistics • Multiple testing • P-hacking • Pseudoreplication • Regression to the mean • Double dipping • Spurious associations • Visualization challenges • Reproducibility, replicability

PREREQUISITES
1) Introductory knowledge of statistics & probability
2) Introductory experience with data wrangling, analysis, & visualization using R/Python.

INSTRUCTOR
Arjun Krishnan
Associate Professor, Department of Biomedical Informatics
University of Colorado Anschutz Medical Campus
arjun.krishnan@cuanschutz.edu | @compbiologist | thekrishnanlab.org

Very proud to be a member of this team. A huge group effort to improve the lives of those with Down syndrome. Thank you to everyone that has helped us along the way.

CU Anschutz Linda Crnic Institute for Down Syndrome@crnicinstitute.bsky.social · last yr.

The Linda Crnic Institute for Down Syndrome is proud to announce that we have been awarded the 2025 Research Collaboration Award at the 2025 @cuanschutz.bsky.social Research Awards! This award recognizes a team for outstanding contributions in research collaborations.

A favorite! Interestingly, Goodhart stated (in 1975): “Any observed statistical regularity will tend to collapse once pressure is placed upon it for control purposes.” Marilyn Strathern generalized it in 1997 to its famous version👇🏽 pmc.ncbi.nlm.nih.gov/articles/PMC...

“When a Measure Becomes a Target, It Ceases to be a Good Measure”

pmc.ncbi.nlm.nih.gov

Atul Butte@atulbutte.bsky.social · 2y ago

“When a measure becomes a target, it ceases to be a good measure." - Goodhart’s Law en.m.wikipedia.org/wiki/Goodhar...

Regularly tempted to write in my NIH grants innovation section: "Funding software that already exists and works well would be highly innovative for the NIH." (I bet half the panel would break down ROFL, but I'm also highly skeptical that I'd get a good score, or that the PO would be amused.)

I participated in a faculty panel a few weeks ago in which senior (ahem) faculty gave advice on careers in academia by pretending luck had very little to do with our success. One piece of advice riled me up, in which it was argued that a reason for their success was their ability to say no. 1/

Same reason that nanopore work with direct clinical application gets published in Annals of Obscurities while the tumor poopome and AlphaFold3 (which wasn’t even competitive in CASP16!) get published in Nature over the objections of highly qualified reviewers

Because it makes for a better $$$ barrier to entry. Broke: we fit a linear model and predicted results of a CRISPR screen Woke: we burned down the Amazon to train a 96-head transformer on 500 million cells and did ALMOST AS WELL as the linear model that runs on my phone